Atlas Trials

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer

Clinical trial NCT03113019 · UNKNOWN

Trial details

NCT number
NCT03113019
Sponsor
Research Institute of Fundamental and Clinical Immunology
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2014-02-11
Primary completion
2017-02-11
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.